MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 421 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $10,014,000 | +43.5% | 166,066 | +9.4% | 0.03% | +36.4% |
| Q1 2016 | $6,980,000 | -5.7% | 151,811 | -0.8% | 0.02% | -8.3% |
| Q4 2015 | $7,398,000 | +12.3% | 153,046 | -1.3% | 0.02% | +9.1% |
| Q3 2015 | $6,589,000 | -18.5% | 155,038 | +119.1% | 0.02% | -15.4% |
| Q2 2015 | $8,081,000 | -3.0% | 70,765 | +9.7% | 0.03% | +8.3% |
| Q1 2015 | $8,330,000 | +33.1% | 64,535 | +2.7% | 0.02% | +33.3% |
| Q4 2014 | $6,257,000 | +0.6% | 62,817 | -0.2% | 0.02% | -5.3% |
| Q3 2014 | $6,221,000 | +27.0% | 62,922 | -1.0% | 0.02% | +35.7% |
| Q2 2014 | $4,897,000 | +17.3% | 63,530 | -2.0% | 0.01% | +16.7% |
| Q1 2014 | $4,175,000 | -3.3% | 64,859 | -4.1% | 0.01% | -7.7% |
| Q4 2013 | $4,317,000 | -2.8% | 67,636 | -8.7% | 0.01% | -7.1% |
| Q3 2013 | $4,441,000 | +19.8% | 74,094 | -1.6% | 0.01% | +16.7% |
| Q2 2013 | $3,706,000 | – | 75,327 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |